 | |
- close
- close
|
EE Times
Nov 26
Comment
The Portuguese DRAM test and assembly operation subsidiary of insolvent Qimonda AG (Munich, Germany) has been offered a financial life line and is taking on a new name, according to local reports.
MedPage Today
Nov 9
Comment
The costs of quality-improvement programs in primary care are substantial and vary considerably, so implementation should be done cautiously, a new study suggested.
EE Times
Oct 13
Comment
DRAM vendor Qimonda AG is to lay off 590 employees at its backend facility in Vila do Conde, Portugal, according to EMS industry website evertiq, which cites Portuguese local press as its source.
Sponsored Topics:
Portugal -...
Fabtech
Oct 12
Comment
In a bid to exploit its semiconductor patent portfolio, insolvent Qimonda is establishing Qimonda Licensing LLC with offices in Fort Lauderdale, Florida and headed by Brian Prather, Qimonda’s previous head of its patent licensing.
PR Newswire
Oct 12
Comment
SAN JOSE, Calif., Oct. 12 /PRNewswire/ -- Atmel® Corporation (Nasdaq: ATML), a leader in touch technology and microcontroller-based solutions, today announced the appointment of Joerg Strughold as Vice President of European Sales. In his new role,
EE Times
Oct 8
Comment
Microprocessor vendor Advances Micro Devices has announced to appoint former Qimonda executive Thomas Seifert as Chief Financial Officer. The CFO position has become vacant since its incumbent Robert Rivet has been promoted to Chief Operations...
EE Times
Sep 28
Comment
A U.S. bankruptcy judge has approved the $172.5 million purchase by Texas Instruments of semiconductor manufacturing equipment from Qimonda's fab in Virginia.
Sponsored Topics:
Semiconductor device fabrication - Qimonda -...
Sep 15
Comment
The stock research section of BioMedReports.com has been expanded to include medical, scientific, and industry research report categories – including five new files for privately-held Quantum Immunologics (QI) related to its experimental...
Sep 6
Comment
On 7/8/09, in the first of four steps leading to an anticipated merger and name change, Mentor Capital (
MNTR.PK
) acquired a 20% ownership stake in an innovative clinical stage cancer immunotherapy company, Quantum Immunologics, Inc. (QI). QI is...
Sep 5
Comment
The stock research section of BioMedReports has been updated to include my 8-page report for Mentor Capital (
MNTR.PK
), which is current as of the 8/28/09 publication date. Highlights from the report that make Mentor's stock a compelling...
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
QI AT A GLANCE
References
| ||||||
|
|
